Literature DB >> 33045383

Characterization and functional insights into the Entamoeba histolytica pyridoxal kinase, an enzyme essential for its survival.

Khaja Faisal Tarique1, Suneeta Devi2, Priya Tomar2, Mohammad Farhan Ali2, Syed Arif Abdul Rehman3, Samudrala Gourinath4.   

Abstract

Pyridoxal 5'-phosphate (PLP) is the active form of vitamin B6 and a cofactor for more than 140 enzymes. This coenzyme plays a pivotal role in catalysis of various enzymatic reactions that are critical for the survival of organisms. Entamoeba histolytica depends on the uptake of pyridoxal (PL), a B6 vitamer from the external environment which is then phosphorylated by pyridoxal kinase (EhPLK) to form PLP via the salvage pathway. E. histolytica cannot synthesise vitamin B6de-novo, and also lacks pyridoxine 5'-phosphate oxidase, a salvage pathway enzyme required to produce PLP from pyridoxine phosphate (PNP) and pyridoxamine phosphate (PMP). Analysing the importance of PLK in E. histolytica, we have determined the high-resolution crystal structures of the dimeric pyridoxal kinase in apo, ADP-bound, and PLP-bound states. These structures provided a snapshot of the transition state and help in understanding the reaction mechanism in greater detail. The EhPLK structure significantly differed from the human homologue at its PLP binding site, and the phylogenetic study also revealed its divergence from human PLK. Further, gene regulation of EhPLK using sense and antisense RNA showed that any change in optimal level is harmful to the pathogen. Biochemical and in vivo studies unveiled EhPLK to be essential for this pathogen, while the molecular differences with human PLK structure can be exploited for the structure-guided design of EhPLK inhibitors.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug target; Entamoeba histolytica; Enzyme kinetics; Pyridoxal 5′-phosphate (PLP); Pyridoxal kinase; X-ray crystallography

Year:  2020        PMID: 33045383     DOI: 10.1016/j.jsb.2020.107645

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  2 in total

1.  Inhibiting Pyridoxal Kinase of Entamoeba histolytica Is Lethal for This Pathogen.

Authors:  Suneeta Devi; Priya Tomar; Khaja Faisal Tarique; Samudrala Gourinath
Journal:  Front Cell Infect Microbiol       Date:  2021-04-16       Impact factor: 5.293

2.  Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their Trophozoite Growth Phase.

Authors:  Alfredo Juárez-Saldivar; Elizabeth Barbosa-Cabrera; Edgar E Lara-Ramírez; Alma D Paz-González; Ana V Martínez-Vázquez; Virgilio Bocanegra-García; Isidro Palos; Nuria E Campillo; Gildardo Rivera
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.